Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz

Author： Cooper Vanessa   Moyle Graeme   Fisher Martin   Reilly Geraldine   Ewan Jacqueline   Liu Hui   Horne Rob  

Publisher： Routledge Ltd

ISSN： 1360-0451

Source： AIDS Care, Vol.23, Iss.6, 2011-06, pp. : 705-713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

By Campo R.   DeJesus E.   Bredeek U. F.   Henry K.   Khanlou H.   Logue K.   Brinson C.   Benson P.   Dau L.   Wang H.   White K.   Flaherty J.   Fralich T.   Guyer B.   Piontkowsky D.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1637-1645

Oxford University Press

Access to resources Recommend Favorite

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

By  

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

By Uy Jonathan   Yang Rong   Wirtz Victoria   Sheppard Louise   Farajallah Awny   McGrath Donnie  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1500-1504

Routledge Ltd

Access to resources Recommend Favorite

Which Patients have Greatest Need for Elvitegravir/Cobicistat/ Emtricitabine/TenofovirDF-Based Therapy?

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 41-51

Bentham Science Publishers

Access to resources Recommend Favorite

Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence

By Mannheimer S. B.   Matts J.   Telzak E.   Chesney M.   Child C.   Wu A. W.   Friedland G.  

AIDS Care, Vol. 17, Iss. 1, 2005-01 ,pp. : 10-22

Routledge Ltd

Access to resources Recommend Favorite